EUVIMEDEUVIMED entdecken
Open Access

Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo

Wenjing Cao, Aria R Trask, Antonia I Bignotti, Lindsey A George, Bhavya S Doshi, Denise E Sabatino, Noritaka Yada, Liang Zheng, Rodney M Camire, X Long Zheng

Journal of Thrombosis and Haemostasis · 2023-12 · 21 (12) · 3477-3489

DOI: 10.1016/j.jtha.2023.09.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-12. Verfasst von Wenjing Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Institute of Reproductive Medicin…. Hauptthemen laut MEDLINE: Hemophilia A, Hemostatics, von Willebrand Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coagulation factor VIII (FVIII) and von Willebrand factor (VWF) circulate as a noncovalent complex, but each has its distinct functions. Binding of FVIII to VWF results in a prolongation of FVIII's half-life in circulation and modulates FVIII's immunogenicity during hemophilia therapy. However, the biological effect of FVIII and VWF interaction on VWF homeostasis is not fully understood. OBJECTIVES: To determine the effect of FVIII in VWF proteolysis and homeostasis in vivo. METHODS: Mouse models, recombinant FVIII infusion, and patients with hemophilia A on a high dose FVIII for immune tolerance induction therapy or emicizumab for bleeding symptoms were included to address this question. RESULTS: An intravenous infusion of a recombinant B-domain less FVIII (BDD-FVIII) (40 and 160 μg/kg) into wild-type mice significantly reduced plasma VWF multimer sizes and its antigen levels; an infusion of a high but not low dose of BDD-FVIII into Adamts13+/- and Adamts13-/- mice also significantly reduced the size of VWF multimers. However, plasma levels of VWF antigen remained unchanged following administration of any dose BDD-FVIII into Adamts13-/- mice, suggesting partial ADAMTS-13 dependency in FVIII-augmented VWF degradation. Moreover, persistent expression of BDD-FVIII at ∼50 to 250 U/dL via AAV8 vector in hemophilia A mice also resulted in a significant reduction of plasma VWF multimer sizes and antigen levels. Finally, the sizes of plasma VWF multimers were significantly reduced in patients with hemophilia A who received a dose of recombinant or plasma-derived FVIII for immune tolerance induction therapy. CONCLUSION: Our results demonstrate the pivotal role of FVIII as a cofactor regulating VWF proteolysis and homeostasis under various (patho)physiological conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHemostaticsvon Willebrand DiseasesHumansMiceAnimalsFactor VIIIvon Willebrand FactorHemorrhageHomeostasis

Stichwörter der Autor:innen

ADAMTS-13coagulation factor VIIIproteolysisregulationthrombosisvon Willebrand factor

Substanzen

Factor VIIIvon Willebrand FactorHemostatics

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Center,…
  • Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Heart, Lung, and Blood Institute
  • Sanofi
  • Takeda Pharmaceuticals U.S.A.

Zitieren

APA

Cao, W., Trask, A. R., Bignotti, A. I., George, L. A., Doshi, B. S., Sabatino, D. E., Yada, N., Zheng, L., Camire, R. M., & Zheng, X. L. (2023). Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo. Journal of Thrombosis and Haemostasis, 21(12), 3477-3489. https://doi.org/10.1016/j.jtha.2023.09.004

Vancouver

Cao W, Trask AR, Bignotti AI, George LA, Doshi BS, Sabatino DE, et al. Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo. Journal of Thrombosis and Haemostasis. 2023;21(12):3477-3489. doi:10.1016/j.jtha.2023.09.004

BibTeX
@article{Cao2023,
  author = {Cao, Wenjing and Trask, Aria R and Bignotti, Antonia I and George, Lindsey A and Doshi, Bhavya S and Sabatino, Denise E and Yada, Noritaka and Zheng, Liang and Camire, Rodney M and Zheng, X Long},
  title = {Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {12},
  pages = {3477--3489},
  doi = {10.1016/j.jtha.2023.09.004}
}
Kostenlos starten →